Literature DB >> 21857153

Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs.

Konstantinos J Mavrakis1, Christina S Leslie, Hans-Guido Wendel.   

Abstract

Individual microRNAs (miRNAs) have been implicated as oncogenes in experimental cancer models and their expression may affect clinical outcomes. To gain a more comprehensive view of miRNA action in leukemia, we analyzed miRNA expression patters in T-cell leukemia ALL (T-ALL) and cross-referenced the results with an unbiased genetic screen and computational analyses.1 We found that multiple microRNAs contribute to leukmogenesis and act as multi-targeted regulators of several tumor suppressor genes. The oncomirs form a network of overlapping and partially redundant interactions that stabilize the malignant phenotype though coordinate repression of cellular failsafe programs. The emerging network pattern of oncomir action is distinct from the notion of single oncogenic 'driver' mutation. We will discuss experimental, diagnostic and therapeutic implications of this concept of miRNA action in cancer.
© 2011 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21857153      PMCID: PMC3218598          DOI: 10.4161/cc.10.17.16959

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  41 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  TargetScreen: an unbiased approach to identify functionally important microRNA targets.

Authors:  Konstantinos J Mavrakis; Hans-Guido Wendel
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

3.  bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA.

Authors:  W Tam; D Ben-Yehuda; W S Hayward
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

5.  Accumulation of miR-155 and BIC RNA in human B cell lymphomas.

Authors:  Peggy S Eis; Wayne Tam; Liping Sun; Amy Chadburn; Zongdong Li; Mario F Gomez; Elsebet Lund; James E Dahlberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

6.  MicroRNA miR-125b causes leukemia.

Authors:  Marina Bousquet; Marian H Harris; Beiyan Zhou; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

7.  Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis.

Authors:  Wayne Tam; Stephen H Hughes; William S Hayward; Peter Besmer
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.

Authors:  Hans-Guido Wendel; Elisa De Stanchina; Jordan S Fridman; Abba Malina; Sagarika Ray; Scott Kogan; Carlos Cordon-Cardo; Jerry Pelletier; Scott W Lowe
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

9.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

10.  Human MicroRNA targets.

Authors:  Bino John; Anton J Enright; Alexei Aravin; Thomas Tuschl; Chris Sander; Debora S Marks
Journal:  PLoS Biol       Date:  2004-10-05       Impact factor: 8.029

View more
  17 in total

Review 1.  The duality of oncomiR addiction in the maintenance and treatment of cancer.

Authors:  Christopher J Cheng; Frank J Slack
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

2.  Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia.

Authors:  Laurent Renou; Pierre-Yves Boelle; Caroline Deswarte; Salvatore Spicuglia; Aissa Benyoucef; Julien Calvo; Benjamin Uzan; Mohamed Belhocine; Agata Cieslak; Judith Landman-Parker; Andre Baruchel; Vahid Asnafi; Françoise Pflumio; Paola Ballerini; Irina Naguibneva
Journal:  Blood Adv       Date:  2017-05-04

3.  Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma.

Authors:  Sumitaka Yamanaka; Nathaniel R Campbell; Fangmei An; Scot C Kuo; James J Potter; Esteban Mezey; Anirban Maitra; Florin M Selaru
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

Review 4.  Aberrant expression of microRNAs in bladder cancer.

Authors:  Hirofumi Yoshino; Naohiko Seki; Toshihiko Itesako; Takeshi Chiyomaru; Masayuki Nakagawa; Hideki Enokida
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

5.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors:  William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

6.  Reprogramming of the microRNA transcriptome mediates resistance to rapamycin.

Authors:  Hana Totary-Jain; Despina Sanoudou; Iddo Z Ben-Dov; Cula N Dautriche; Paolo Guarnieri; Steven O Marx; Thomas Tuschl; Andrew R Marks
Journal:  J Biol Chem       Date:  2013-01-08       Impact factor: 5.157

7.  Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs.

Authors:  Valentina Fonsato; Federica Collino; Maria Beatriz Herrera; Claudia Cavallari; Maria Chiara Deregibus; Barbara Cisterna; Stefania Bruno; Renato Romagnoli; Mauro Salizzoni; Ciro Tetta; Giovanni Camussi
Journal:  Stem Cells       Date:  2012-09       Impact factor: 6.277

Review 8.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

9.  Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2.

Authors:  Haoran Li; Burton B Yang
Journal:  Oncotarget       Date:  2012-12

10.  Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway.

Authors:  Nehad M Alajez; Wei Shi; Dennis Wong; Michelle Lenarduzzi; John Waldron; Ilan Weinreb; Fei-Fei Liu
Journal:  Oncotarget       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.